Nicht aus der Schweiz? Besuchen Sie lehmanns.de
Patent Litigation in the Pharmaceutical and Biotechnology Industries - Dr. Gareth E. Morgan

Patent Litigation in the Pharmaceutical and Biotechnology Industries

Buch | Hardcover
270 Seiten
2013
Woodhead Publishing Ltd (Verlag)
978-1-907568-20-6 (ISBN)
CHF 218,20 inkl. MwSt
  • Titel ist leider vergriffen;
    keine Neuauflage
  • Artikel merken
Written by a leading practitioner in the field, Patent litigation in the pharmaceutical and biotechnology industries focuses on the key subject of multi-jurisdictional patent litigation strategies and product lifecycle management in the pharmaceutical and biotechnology industries. This book therefore looks at the characteristics and strategies typically employed in fighting multi-jurisdictional litigation within these industries. In particular, patentability and the enforceability of biotechnological inventions are examined as they remain one of the most fluid, commercially important and emotive topics in the patent industry.

Gareth E. Morgan studied Biochemistry at Jesus College, Oxford University, and obtained a degree with first class honours in 1991. He then studied for a D.Phil in molecular biology, focussing on the regulation of the gene for human clotting factor IX. His legal studies were completed at BPP Law School in London and he qualified as a solicitor within the IP Department of Herbert Smith in 2000. He then moved to Taylor Wessing in 2005 and subsequently became a partner in the Patents Group in the London office in 2008. In 2010 he moved to DLA Piper to take up a role within the Intellectual Property and Technology Group, again in the firm's London office, specialising in patent-related matters and medicinal regulatory advice. He qualified as a Solicitor Advocate in 2004 and is an Associate Member of both CIPA (the Chartered Institute of Patent Attorneys) and the UNION (European Union of Intellectual Property Practitioners). He is also a member of the AIPPI.

Choosing your forum; Litigating in the US; Litigating in Europe; Litigating pharma patents; Litigating biotechnology patents; The US ITC regime; Medicinal regulatory considerations; Patent term extension and the SPC regime; A unified patent litigation system for Europe; Conclusions.

Reihe/Serie Woodhead Publishing Series in Biomedicine ; No. 26
Verlagsort Cambridge
Sprache englisch
Maße 156 x 234 mm
Themenwelt Naturwissenschaften Biologie
Recht / Steuern EU / Internationales Recht
Recht / Steuern Wirtschaftsrecht Urheberrecht
Technik Umwelttechnik / Biotechnologie
ISBN-10 1-907568-20-4 / 1907568204
ISBN-13 978-1-907568-20-6 / 9781907568206
Zustand Neuware
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich
und verwandte Schutzrechte

von Heinrich Hubmann; Manfred Rehbinder; Alexander Peukert

Buch | Softcover (2023)
C.H.Beck (Verlag)
CHF 48,85
Kommentar

von Herbert Grziwotz; Jörn Heinemann

Buch | Hardcover (2024)
Carl Heymanns (Verlag)
CHF 179,95